Ukraine allocated 3.2 billion UAH for medicines: oncology, rare and cardiovascular diseases.
Increased funding for medical purchases
According to inkorr.com: The state enterprise 'Medical Purchases' received a significant increase in funding — 3.2 billion hryvnias. These funds will be directed towards the purchase of medicines necessary for the treatment of cardiovascular, rare and oncological diseases. More than 400 different items are planned to be purchased.
The General Director of the State Enterprise 'Medical Purchases of Ukraine' Oleg Klyots noted:
“These funds will be directed towards the urgent needs of patients, in particular for the treatment of cardiovascular diseases and other areas.”
Funding for various medical areas
Among the expenditures for the treatment of cardiovascular diseases, funding is also provided for the therapy of childhood hemophilia, the production of products for neurosurgery, childhood oncology, and other medical needs. It is expected that the tender for the purchase of medicines for hepatitis treatment will allow significant savings.
Promises regarding the effective use of funding instill optimism in improving the medical system in Ukraine. This decision will be an important step towards improving the availability and quality of medical care, which is critically necessary for patients in the difficult conditions of today.
Read also
- Fire Point, a Ukrainian Manufacturer, Produces 200 Flamingo Missiles Monthly and Aims for Ballistic Capabilities
- Russia Weighs Seizing $40 Billion in Private Pension Funds to Finance Military Campaign
- As Russian Stocks Crash by Double Digits, the Wealthy Pivot to Crypto and Overseas Real Estate
- Trump Says Talks Possible as Oil Prices Crash After US and Iran Halt Attacks
- Sanctions Disguise Airline Bankruptcies as Rostec Plans a Restructuring of Russian Aviation
- Drone Strikes on CPC Terminal Drive Kazakhstan's Daily Oil Output Down to 133,200 Metric Tons

